Robert H. Oakley, PhD, John A. Cidlowski, PhD 

Slides:



Advertisements
Similar presentations
Molecular Basis for Relationship between Genotype and Phenotype DNA RNA protein genotype function organism phenotype DNA sequence amino acid sequence transcription.
Advertisements

Transcriptional-level control (10) Researchers use the following techniques to find DNA sequences involved in regulation: – Deletion mapping – DNA footprinting.
More regulating gene expression. Fig 16.1 Gene Expression is controlled at all of these steps: DNA packaging Transcription RNA processing and transport.
Molecular Basis for Relationship between Genotype and Phenotype DNA RNA protein genotype function organism phenotype DNA sequence amino acid sequence transcription.
Caption N-terminal domain A/B domain: ligand-independent domain AF1: Activation Function 1 DBD: DNA Binding Domain LBD: Ligand Binding Domain: ligand-dependent.
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Regulation of Gene Expression in Eukaryotes
John W. Bloom, MD  Journal of Allergy and Clinical Immunology 
Expression of Human Genes
Molecular regulation of mast cell activation
Defects of class-switch recombination
Ian M. Adcock, PhD, Kittipong Maneechotesuwan, MD, Omar Usmani, MBBS 
Laurent L'homme, PhD, David Dombrowicz, PhD 
Concept 18.2: Eukaryotic gene expression can be regulated at any stage
Gene Regulation.
The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology  Mate Kiss, Zsolt Czimmerer,
Biology of common β receptor–signaling cytokines
Social stress and asthma: The role of corticosteroid insensitivity
Vemuri B. Reddy, PhD, Thomas A
Signaling molecules as therapeutic targets in allergic diseases
Figure 2 Oestrogen receptor signalling pathways
Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: Multifactorial states of clinical importance  Tomoshige Kino, MD, PhD, George P.
A novel mutation c.118delA in exon 1 of the androgen receptor gene resulting in complete androgen insensitivity syndrome within a large family  Karel.
Is 9 more than 2 also in allergic airway inflammation?
Molecular regulation of mast cell activation
Biology of the immunomodulatory molecule HLA-G in human liver diseases
TNF-α–induced protein 3 (A20): The immunological rheostat
Practice Notes from the AAAI
David J. Cousins, PhD, Joanne McDonald, BSc, Tak H. Lee, MD, ScD 
Antimicrobial peptides and the skin immune defense system
Neurodevelopment on Route p63
The Wiskott-Aldrich syndrome
Pharmacogenomic variability and anaesthesia
FGFR Signaling as a Target for Lung Cancer Therapy
Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells
IL-33 in clinical practice: Size matters?
Peter J. Barnes, FRS, FMedSci 
HLA and Pregnancy: The Paradox of the Fetal Allograft
Vemuri B. Reddy, PhD, Thomas A
Met as a therapeutic target in HCC: Facts and hopes
YouFei Guan, M.D., Ph.D., Matthew D. Breyer  Kidney International 
Development of Androgen Receptor Antagonists with Promising Activity in Castration- Resistant Prostate Cancer  Howard C. Shen, Steven P. Balk  Cancer Cell 
Arati Khanna-Gupta  Experimental Hematology 
Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species  László Maródi, MD, PhD, Sophie Cypowyj, PhD, Beáta Tóth, PhD,
AKT/PKB Signaling: Navigating the Network
Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-κB pathways in rhinovirus- infected epithelial cells  Rommy Koetzler, MD, MSc, Raza S.
Charles E. Reed, MD, Hirohito Kita, MD 
News & Notes Journal of Allergy and Clinical Immunology
The role of histone deacetylases in asthma and allergic diseases
Molecular mechanisms of IgE regulation
Antisense molecules: A new class of drugs
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease  Javier Milara, PhD, PharmD,
Weiguo Chen, PhD, Gurjit K. Khurana Hershey, MD, PhD 
Modes of p53 Regulation Cell
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Update on glucocorticoid action and resistance
News & Notes Journal of Allergy and Clinical Immunology
Torsten Klengel, Elisabeth B. Binder  Neuron 
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Claus Bachert, MD, PhD, Luo Zhang, MD, Phillippe Gevaert, MD 
Robert P. Schleimer, PhD  Journal of Allergy and Clinical Immunology 
Volume 7, Issue 1, Pages 1-11 (July 1997)
News & Notes Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Torsten Klengel, Elisabeth B. Binder  Neuron 
Update on glucocorticoid action and resistance
Dendritic Tau in Alzheimer’s Disease
Epigenetic mechanisms and the development of asthma
Presentation transcript:

The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease  Robert H. Oakley, PhD, John A. Cidlowski, PhD  Journal of Allergy and Clinical Immunology  Volume 132, Issue 5, Pages 1033-1044 (November 2013) DOI: 10.1016/j.jaci.2013.09.007 Copyright © 2013 Terms and Conditions

Fig 1 Regulation of glucocorticoid hormone secretion by the hypothalamic-pituitary-adrenal (HPA) axis. CRH, Corticotropin-releasing hormone. Journal of Allergy and Clinical Immunology 2013 132, 1033-1044DOI: (10.1016/j.jaci.2013.09.007) Copyright © 2013 Terms and Conditions

Fig 2 GR domain structure and sites of posttranslational modification. Shown are the domains of the GR and regions of the receptor involved in transactivation (AF1 and AF2), dimerization, nuclear localization, and hsp90 binding. Also depicted are the amino acid residues modified by phosphorylation (P), sumoylation (S), ubiquitination (U), and acetylation (A). Numbers are for human GR. Journal of Allergy and Clinical Immunology 2013 132, 1033-1044DOI: (10.1016/j.jaci.2013.09.007) Copyright © 2013 Terms and Conditions

Fig 3 GR signaling pathways. The glucocorticoid-activated GR regulates gene expression in 3 primary ways: binding directly to DNA (A), tethering itself to other DNA-bound transcription factors (B), or binding directly to DNA and interacting with neighboring DNA-bound transcription factors (C). The GR can also signal in a nongenomic manner through alterations in the activity of various kinases. BTM, Basal transcription machinery; PI3K, phosphoinositide 3-kinase; STAT, signal transducer and activator of transcription. Journal of Allergy and Clinical Immunology 2013 132, 1033-1044DOI: (10.1016/j.jaci.2013.09.007) Copyright © 2013 Terms and Conditions

Fig 4 GR splice variants. The GR primary transcript is composed of 9 exons. Exon 2 encodes the NTD, exons 3 to 4 encode the DBD, and exons 5 to 9 encode the hinge region (H) and LBD. GRα results from splicing exon 8 to the beginning of exon 9. GRβ, GRγ, GR-A, and GR-P are generated by the depicted alternative splicing events. Journal of Allergy and Clinical Immunology 2013 132, 1033-1044DOI: (10.1016/j.jaci.2013.09.007) Copyright © 2013 Terms and Conditions

Fig 5 GR translational isoforms. Translation initiation from 8 different AUG start codons in the single GRα mRNA (location of the AUG start codons indicated by an asterisk) produces 8 receptor isoforms with progressively shorter amino NTDs. The numbers for the initiator methionines and AF1 region (amino acids 77-262) are for the human GRα protein. UTR, Untranslated region. Journal of Allergy and Clinical Immunology 2013 132, 1033-1044DOI: (10.1016/j.jaci.2013.09.007) Copyright © 2013 Terms and Conditions